I agree with you and Fattchoi.
However, the sort of investment if some big Pharma wants to seize upon ‘potential’ won’t be confined to Roche protecting it’s revenue stream and profit margins, or the risk of losing it by some other savvy company swallowing IMU or just Hervaxx.
Nor is it likely to just GSK who might be interested. Recent articles about Gilead confirm it is no secret they are cashed up for the right investment. They are not alone.
Remission or non-progression, reduction in tumour size, increased longevity and no toxicity and what LC has said about B cell platform is collectively massive.
The ‘potential’ of the product is massive based on interim results.
Big Pharma interest should also be massive.
All in good time.
Go Imugene
PDS
-
- There are more pages in this discussion • 806 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.3¢ | $255.7K | 18.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 18692454 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4515891 | 5 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |